» Articles » PMID: 29786411

BAD Transmission and SAD Distribution: a New Scenario for Critical Limb Ischemia

Overview
Date 2018 May 23
PMID 29786411
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Most of the studies on peripheral artery disease (PAD) focused on above-the-ankle artery disease, while less is known about foot artery disease. We hypothesize a scenario were two different diseases can be present in PAD patients, big artery disease (BAD) and small artery disease (SAD), overlapping at the foot level; the aim of this study is to evaluate their prevalence and their correlation with risk factors and critical limb ischemia (CLI) in a large cohort of patients with symptomatic PAD.

Methods: We retrospectively reviewed 1915 limbs of 1613 patients (502 females, mean age 72.4±10.8 years) who underwent angiography between September 2009 and November 2013. Age, sex, diabetes, smoke history, high blood pressure, dialysis and BMI were considered as risk factors. Logistic regression was performed to test the association of arterial lesions patterns and CLI, and to evaluate the association between risk factors and lesion localization.

Results: SAD was present in 414 patients (25.2%). Patients with disease of any of plantar, dorsalis pedis arteries and SAD faced higher risk of CLI (OR=13.25, 95% CI: 1.69-104.16). SAD was associated with diabetes and dialysis (both: OR=4.85; dialysis only: OR=3.60; diabetes only: OR=1.70; none: reference OR; P<0.01), weight (underweight: OR=1.10; normal: reference OR; overweight: OR=0.81; obese: OR=0.60; P=0.03), while women and tobacco smokers were less likely to have SAD (women: OR=0.68; P<0.01; tobacco use: OR=0.54; P<0.01).

Conclusions: SAD was strongly and independently associated with CLI, diabetes and dialysis. Thus, SAD should be regarded as a leading actor in CLI.

Citing Articles

The Immune-Centric Revolution Translated into Clinical Application: Peripheral Blood Mononuclear Cell (PBMNC) Therapy in Diabetic Patients with No-Option Critical Limb-Threatening Ischemia (NO-CLTI)-Rationale and Meta-Analysis of Observational....

Rehak L, Giurato L, Monami M, Meloni M, Scatena A, Panunzi A J Clin Med. 2024; 13(23).

PMID: 39685690 PMC: 11642624. DOI: 10.3390/jcm13237230.


A Novel Challenge Beyond the Pinnacle: Intravascular Ultrasound-Guided Percutaneous Deep Venous Arterialization.

Nakama T Cardiovasc Intervent Radiol. 2024; 47(12):1737-1738.

PMID: 39528707 DOI: 10.1007/s00270-024-03899-3.


Effectiveness of autologous mononuclear cells as adjuvant therapy in patients with ischaemic diabetic foot ulcers receiving indirect lower limb revascularization.

Marco M, Luigi U, Valeria R, Ermanno B, Carlo M, Maria R Acta Diabetol. 2024; .

PMID: 39287795 DOI: 10.1007/s00592-024-02375-1.


One-Year Analysis of Autologous Peripheral Blood Mononuclear Cells as Adjuvant Therapy in Treatment of Diabetic Revascularizable Patients Affected by Chronic Limb-Threatening Ischemia: Real-World Data from Italian Registry ROTARI.

Furgiuele S, Cappello E, Ruggeri M, Camilli D, Palasciano G, Guerrieri M J Clin Med. 2024; 13(17).

PMID: 39274487 PMC: 11396002. DOI: 10.3390/jcm13175275.


Determining the Best Noninvasive Test for Peripheral Arterial Disease Diagnosis to Predict Diabetic Foot Ulcer Healing in Patients Following Endovascular Revascularization.

Alvaro-Afonso F, Garcia-Alvarez Y, Garcia-Morales E, Flores-Escobar S, De Benito-Fernandez L, Alfayate-Garcia J Healthcare (Basel). 2024; 12(16).

PMID: 39201221 PMC: 11353590. DOI: 10.3390/healthcare12161664.